Navigation Links
Study suggests new treatment option to reduce metastasis in ovarian cancer
Date:1/27/2011

A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.

Researchers at the Georgia Institute of Technology have formed a startup company and are working with a medical device firm to design a prototype treatment system that would use magnetic nanoparticles engineered to capture cancer cells. Added to fluids removed from a patient's abdomen, the magnetic nanoparticles would latch onto the free-floating cancer cells, allowing both the nanoparticles and cancer cells to be removed by magnetic filters before the fluids are returned to the patient's body.

In mice with free-floating ovarian cancer cells, a single treatment with an early prototype of the nanoparticle-magnetic filtration system captured enough of the cancer cells that the treated mice lived nearly a third longer than untreated ones. The researchers expect multiple treatments to extend the longevity benefit, though additional research will be needed to document that and determine the best treatment options.

"Almost no one dies from primary ovarian cancer," said John McDonald, a professor in Georgia Tech's School of Biology and chief research scientist of Atlanta's Ovarian Cancer Institute. "You can remove the primary cancer, but the problem is metastasis. A good deal of the metastasis in ovarian cancer comes from cancer cells sloughing off into the abdominal cavity and spreading the disease that way."

The removal system being developed by McDonald and postdoctoral fellow Ken Scarberry who is also CEO of startup company Sub-Micro should slow tumor progression in humans. It may reduce the number of free-floating cancer cells enough that other treatments, and the body's own immune system, could keep the disease under cont
'/>"/>

Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology Research News
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. First study of dispersants in Gulf spill suggests a prolonged deepwater fate
2. Study: Tiger numbers could triple if large-scale landscapes are protected
3. IU study: Humans critical ability to throw long distances aided by an illusion
4. Study of nutrition, Alzheimers links hampered by research approach
5. New study of environmental contaminants in breast milk
6. How the hat fits: Structural biology study reveals shape of epigenetic enzyme complex
7. UC Davis study shows plants moved downhill, not up, in warming world
8. University of Illinois study confirms glycerin as a feasible feedstuff for swine
9. University of Maryland shares NSF grant to study urban development impact
10. Study finds psychological, environmental benefits of horticultural activities
11. New study shows soy protein lowers non-HDL cholesterol significantly more than milk protein
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study suggests new treatment option to reduce metastasis in ovarian cancer
(Date:9/30/2014)... New England Journal of Medicine reports positive results ... crizotinib against the subset of lung cancer marked by ... of 50 patients with advanced non-small cell lung cancer ... was 72 percent, with 3 complete responses and 33 ... takes for the disease to resume its growth after ...
(Date:9/30/2014)... in urban and farm runoff in Hawaii is causing ... , The study, published Tuesday in the peer-reviewed ... the runoff ends up in algae that the turtles ... eyes, flippers and internal organs. , Scientists at Duke ... and Atmospheric Administration (NOAA) conducted the study to better ...
(Date:9/30/2014)... want your doctor to know what goes wrong with your ... idea to know what "normal" actually is. That,s where a ... the FASEB Journal comes in. In ... key set of molecules that can help scientists "see" which ... What,s more, they found never-before-detected gene activity and that men ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Scientists identify which genes are active in muscles of men and women 2
... and zanamivir, are highly effective when given as ... the influenza virus, according to an analysis of ... Research Center, University of Michigan and University of ... the American Journal of Epidemiology. The analysis also ...
... for granted when it is carried out by the ... when scientists devise new ways for molecules to self ... , Researchers with the Macromolecules and Interfaces Institute (MII ... development in the online issue for the Journal of ...
... Center have identified a subgroup of hard-to-treat breast cancers ... used in the treatment of breast tumors. They ... which may help identify patients most likely to benefit ... in a clinical trial anticipated to begin at the ...
Cached Biology News:Antivirals effectively curb influenza virus 2Antivirals effectively curb influenza virus 3Molecular signature may identify cisplatin-sensitive breast tumors 2Molecular signature may identify cisplatin-sensitive breast tumors 3
(Date:9/30/2014)... a well-known optical phenomenon called thin-film interference, a ... the ability to "paint" ultra-thin coatings onto a ... making future, flexible electronic devices, creating advanced solar ... ships and spacecraft with extremely lightweight decorative logos. ... it becomes iridescent, revealing a myriad of colors ...
(Date:9/30/2014)... 30, 2014 Shimadzu Scientific Instruments ... easy-to-use and highly precise tool for measuring displacement ... elongation. With 1000-mm maximum movement distance, the DSES-1000 ... a gauge length of 10 mm. In addition, ... above 50-mm stroke and within +/- 100 µm ...
(Date:9/30/2014)... , Sept. 30, 2014  RegeneRx Biopharmaceuticals, ... announced that it has received a Canadian Patent ... Actin-Sequestering Peptides.  This patent includes claims using thymosin ... other actin-sequestering peptides for these purposes.  The patent ... RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... 2014  KemPharm, Inc., a clinical-stage specialty pharmaceutical ... proprietary new molecular entity (NME) prodrugs, announced today ... (USPTO) issued U.S. Patent No. 8,816,083 to KemPharm ... Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of ... The patent, which extends through 2032, ...
Breaking Biology Technology:Taking thin films to the extreme 2Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... Europe Aviation is very proud to receive its accreditation," ... "For more than 10 years our vision in the ... and BAR) has been to operate in a safe ... in France as well as facilities in East Europe, ...
... progress of plant-derived insulin program, scheduled to ... TSX symbol: SBS, CALGARY, July 29 /PRNewswire-FirstCall/ ... a portfolio of therapeutic,proteins for metabolic and cardiovascular ... New Drug (IND) application for,safflower-produced recombinant human insulin ...
... First Fully-Automated Random Access ... AACC Meeting, SUNNYVALE, Calif., July 29 ... Infinity-48 high-throughput system,at the 2008 American Association ... The newest addition to Cepheid,s GeneXpert family ...
Cached Biology Technology:First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 2First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 3First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies 4SemBioSys submits IND for safflower-produced insulin to U.S. FDA 2SemBioSys submits IND for safflower-produced insulin to U.S. FDA 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 2Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 4
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
in vitro Translation, Accessory Products...
Biology Products: